THE JOHN INSALL AWARD: Unicompartmental Knee Replacement
| Autor: | John J. Callaghan, Jeremy J. Gardner, David A. Vittetoe, Patrick M. Sullivan, Steve S. Liu, Richard C. Johnston, Michael R O'Rourke, Devon D. Goetz |
|---|---|
| Rok vydání: | 2005 |
| Předmět: |
Reoperation
musculoskeletal diseases medicine.medical_specialty Knee Joint medicine.medical_treatment Unicompartmental knee replacement Osteoarthritis medicine Humans Orthopedics and Sports Medicine In patient Result study Arthroplasty Replacement Knee Aged Aged 80 and over business.industry Disease progression General Medicine Middle Aged Osteoarthritis Knee musculoskeletal system medicine.disease Arthroplasty Surgery Surgery knee Equipment Failure Analysis Radiography Treatment Outcome Unicompartmental knee Knee Prosthesis business Follow-Up Studies |
| Zdroj: | Clinical Orthopaedics and Related Research. 440:27-37 |
| ISSN: | 0009-921X |
| DOI: | 10.1097/01.blo.0000185451.96987.aa |
| Popis: | UNLABELLED We report the results of a minimum 21-year followup of a consecutive series of 103 patients who had 136 Marmor cemented unicompartmental knee replacements done between 1975 and 1982. Patients were evaluated clinically and radiographically. At minimum 21-year followup 14 patients (19 knees) were alive, 87 patients (115 knees) had died, and only two patients (two knees) were lost to followup. The average age at surgery was 70.9 years. The average followup Hospital for Special Surgery knee score was 58. The average Knee Society final followup clinical and functional scores averaged 72 and 53 points, respectively. Nineteen knees (14%) were revised during the 21-year followup period: nine for progression of disease, eight for loosening, and two for pain, at an average of 10.6 years (range, 1-22 years). Of the 19 knees in the 14 patients who were still alive at final followup, seven (37%) were revised: two for tibial loosening, four for disease progression, and one for pain. Unicompartmental knee replacements in this relatively older age group of patients performed well at minimum 21-year followup. Although we are encouraged by these results, only 22% were done in patients who were younger than 65 years at the time of surgery and the results in this group were significantly less durable. LEVEL OF EVIDENCE Therapeutic study, Level IV-1 (case series). See the Guidelines for Authors for a complete description of levels of evidence. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|